Janiczek Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$404 Hold
17
﹤0.01% 1011
2024
Q1
$495 Hold
17
﹤0.01% 1004
2023
Q4
$565 Hold
17
﹤0.01% 988
2023
Q3
$479 Hold
17
﹤0.01% 976
2023
Q2
$587 Hold
17
﹤0.01% 892
2023
Q1
$522 Hold
17
﹤0.01% 904
2022
Q4
$557 Hold
17
﹤0.01% 902
2022
Q3
$1K Hold
17
﹤0.01% 805
2022
Q2
$1K Hold
17
﹤0.01% 825
2022
Q1
$1K Hold
17
﹤0.01% 821
2021
Q4
$1K Hold
17
﹤0.01% 877
2021
Q3
$1K Hold
17
﹤0.01% 856
2021
Q2
$2K Buy
17
+4
+31% +$340 ﹤0.01% 745
2021
Q1
$1K Buy
13
+3
+30% +$298 ﹤0.01% 772
2020
Q4
$1K Buy
+10
New +$797 ﹤0.01% 711

Other funds holding ARKG

Janiczek Wealth Management's ARKG Position: Q2 2024 in Review

Janiczek Wealth Management held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2024 at 17 shares worth $404. The position accounts for ﹤0.01% of the portfolio, ranked #1011.

Janiczek Wealth Management first reported a position in ARKG in Q4 2020 and has held it in 15 quarters since. The position peaked at $2K in Q2 2021. 261 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

  • Janiczek Wealth Management held 17 shares of ARK Genomic Revolution ETF worth $404 as of Q2 2024.
  • Janiczek Wealth Management left its ARK Genomic Revolution ETF share count unchanged in Q2 2024.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Janiczek Wealth Management's portfolio in Q2 2024, its #1011 holding.
  • Janiczek Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 15 quarters since.
  • Janiczek Wealth Management's ARK Genomic Revolution ETF position peaked at $2K in Q2 2021.
  • 261 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on Janiczek Wealth Management's 13F filing for Q2 2024, filed 25 Jul 2024.